The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

Research Objective We will utilize human induced pluripotent stem cells derived from Duchenne muscular dystrophy (DMD) patients for drug testing and drug discovery for this rare genetic disease.

Translational Candidate Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells Area of Impact Pulmonary Arterial Hypertension (PAH), initially associated ...

Les membres du public assistant à la réunion dans un lieu de téléconférence auront la possibilité de formuler des commentaires publics à chaque endroit, avec les mêmes limitations que celles imposées ...

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

South San Francisco, CA, March 27, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, approved new and ...

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session. THE ORDER OF ...

El Instituto de Medicina Regenerativa de California y su Comité de Supervisión de Ciudadanos Independientes, y sus subcomités, cumplen con la Ley de Estadounidenses con Discapacidades (ADA, por sus ...

B 型血友病是一种由血浆中缺乏凝血因子 IX (FIX) 引起的出血性疾病，影响大约三万分之一的男性。 FIX 蛋白功能失调的患者无法形成正常血栓，并且容易发生危及生命的出血。 他们还遭受关节 ...

Los miembros del público pueden asistir a esta reunión en persona en la dirección impresa arriba o de forma remota a través de las opciones que se enumeran a continuación. Instrucciones para ...

研究表明，不仅转录因子，而且基础转录装置的组成也对肝细胞的分化阶段表现出特异性。这一发现可能有助于从未成熟的祖细胞中生成肝细胞，其功能和增殖能力比使用当前方案生成的细胞更 ...